NSTDA allows experts to analyze the vaccine AstraZeneca. To plan the vaccination of each group next. Along with reiterating the production of AstraZeneca vaccine in Thailand as planned It is sending to Scotland and the United States to check the quality. In order to return the injection as planned in early June
Today (8 Apr 2021) at the Ministry of Public Health, Dr. Nakorn Prem Sri, director of the National Vaccine Institute. It discusses reports from the UK Drug and Health Products Regulatory Agency (MHRA) and the European Medicines and Health Products Regulatory Agency (EMA) on cases of thromboembolism with thrombocytopenia. Who received the COVID-19 vaccine Of AstraZeneca
“Two agencies concluded that There is a possibility that these side effects may be related to COVID-19 vaccine. Of AstraZeneca But there is no definite conclusion Both agencies will check for evidence. It was noted that Side effects that occur after the first injection are considered to be very rare. Or may occur at the rate of 2 people per injection of 1 million people “
Previous reports have stated that The rate of thrombosis is also related to the population, race and lifestyle of the people. But Thailand and other Asian countries It has a lower rate of thrombosis than in European countries. Which the National Vaccine Institute, including the FDA, has been closely monitoring the information Including the announcement from the World Health Organization consisting of To bring information to experts in Thailand to further advise on how to use each group.
However, the World Health Organization has not yet made a recommendation to stop the COVID-19 vaccine. Of AstraZeneca But many countries choose to inject only in the elderly 40 million doses of the vaccine have been used by the UK and European countries.
Dr. Nakorn said that the AstraZeneca vaccine is now produced in Thailand by Siam BioScience. Do well And the plan has been implemented in each production cycle that works very well. The vaccine is produced at a time of 2,000 liters and is currently in the process of delivering the vaccine for quality inspection to AstraZeneca’s laboratory. In Scotland and the United States The results are expected to gradually return around mid-April. To be able to deliver the first lot of vaccines to Thailand as planned in early June 2021 for 5-10 million doses per month. Consistent with the vaccine distribution plan of the Ministry of Public Health.